Helius Therapeutics

In this October issue, we mark a milestone month for Helius, highlight two great visits to Helius HQ, share yet another podcast featuring our CEO Carmen Doran, and conclude with some topical education regarding medicinal cannabis and driving.

🌏 Big news! We're excited to announce the first of our HTL (Helius Therapeutics Limited) products is now available across Australia.  Thanks to our partnership with Novachem Pty Ltd, a leading distributor of medicinal cannabis products, Australian patients can now access high-quality, NZ-made, GMP-certified treatments via key distributors like Cannabis Warehouse, The Entourage Effect, and Leafio. “Having seen first-hand the quality of the facilities and the commitment to patient outcome, Novachem is confident that the HTL products will add substantial value to patients in Australia. Having these products tested in Australia to Australian standards adds an additional level of surety to prescribers and patients alike”. Andrew Heath Novachem Medical Products Manager.

A very warm welcome to Hardy Susanto, who has joined the Helius team as an Analytical Development Intern, providing support for our busy operations at our GMP-certified R&D and analytical lab. Hardy recently graduated with a Master’s in Chemistry from the University of Auckland, and has previous experience in laboratory settings as a technician, and in community pharmacy settings as a pharmacy assistant.  

3 years after we launched in New Zealand, we are pleased to be supporting Australian patients via the HTL brand and our partner in market Novachem Pty Ltd

Thanks to the team from Bank of New Zealand for stopping by today! Pictured here with our Helius Finance Manager, Abbey Rutz, Kurt Barrow, Bridie Walsh, Tania Sidhu, Paul Kim We talked all things #medicinalcannabis from rising prescription numbers and acceptance here in New Zealand to the exciting changes in the NZ export rules earlier this year and what’s ahead! A massive thanks for your ongoing support as “hands-on” banking partners

A very warm welcome to the first of our Callaghan Innovation summer interns, Zachary McKay. Zachary joins the Extracted Products team, and will assist in developing new formulations and extracting from New Zealand grown biomass for our range of medicinal cannabis products. Zachary has recently graduated with a Bachelor of Science from the The University of Auckland, specialising in Biomedical Science, and holds a keen interest in Plant Science. #newhire #welcome #medicinalcannabis #summerinternship #futuretalent

Our CEO Carmen Doran joined the NBR - National Business Review's recent podcast to discuss the challenges and successes of New Zealand’s medicinal cannabis industry. From navigating stringent local regulations to making Helius’ first export to Denmark,  Carmen shares how Helius is leading the charge to build a global cannabis business right from NZ. 🎧 For the full interview visit: Spotify - https://lnkd.in/gRbkzdyK iHeartRadio - https://lnkd.in/gbbE2ZgS #aotearoa #business #nz #newzealand #journalism #cannabis #regulation #cannabiz Carmen Doran Sally King Shane Le Brun

HIRING: Exciting new role at Helius - get in touch with Baxter Executive Search to find out more.

As we continue to expand our global footprint and help more patients around the world, it is great to have the continued support of our NZ government. Talking all things #medicinalcannabis, #nzexports, #regulations and doing business in the European Union were the themes of the day when Carmen Doran, CEO welcomed: - Rod Harris, Europe Divisional Manager at New Zealand Ministry of Foreign Affairs & Trade - Ross Batchelor, Incoming Deputy Head of Mission at New Zealand Embassy Berlin - Tom Butler, Foreign Policy Officer at New Zealand Ministry of Foreign Affairs & Trade

NEW JOB ALERT: We are GROWING! Do you know someone that would be a great fit for our Cultivation team growing high quality #medicinalcannabis right here in Aotearoa New Zealand? Share the link below: